Evidence map›Paper›PMID 15351779›Full record

ArticleBritish journal of pharmacology2004

New insights into the human 5-HT4 receptor binding site: exploration of a hydrophobic pocket.

Lucie Rivail, Mireille Giner, Monique Gastineau, Magali Berthouze, Jean-Louis Soulier, Rodolphe Fischmeister, Frank Lezoualc'h, Bernard Maigret, Sames Sicsic, Isabelle Berque-Bestel

Open access · greenAbstract readComparative Study
In one paragraph

Article in British journal of pharmacology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Lucie RivailBiocis, UMR-8076 (CNRS), Faculté de Pharmacie, Université Paris-Sud, 5 rue JB Clément, 92296 Châtenay-Malabry, France.
Mireille Giner
Monique Gastineau
Magali Berthouze
Jean-Louis Soulier
Rodolphe Fischmeister
Frank Lezoualc'h
Bernard Maigret
Sames Sicsic
Isabelle Berque-Bestel
Centre National de la Recherche Scientifique · FRInserm · FRLaboratoire d'Énergétique Moléculaire et Macroscopique, Combustion · FRUniversité de Lorraine · FRUniversité Paris-Sud · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A body of evidences suggests that a hydrophobic pocket of the human 5-HT(4) receptor contributes to the high affinity of some bulky 5-HT(4) ligands. A thorough study of this pocket was performed using mutagenesis and molecular modeling. Ligand binding or competition studies with selected bulky ligands (RS39604, RS100235, [(3)H]GR113808 and ML11411) and small ligands (5-HT and ML10375) were carried out on wild-type and mutant receptors (W7.40A/F, Y7.43F, R3.28L) transiently transfected in COS-7 cells. The functional activity of the mutated receptors was evaluated by measuring the ability of 5-HT to stimulate adenylyl cyclase. For W7.40F mutation, no changes in the affinity of studied ligands and in the functional activity of the mutant receptor were observed, in contrary to W7.40A mutation, which abolished both binding of ligands and 5-HT-induced cAMP production. Mutation R3.28L revealed a totally silent receptor with a basal level of cAMP production similar to the mock control despite its ability to product cAMP in the presence of 5-HT. Moreover, a one order loss of affinity of RS39604 and a 45-fold increase of ML11411 affinity were observed. Mutation Y7.43F modified the affinity of GR113808, which displays a 13-fold lower affinity for the mutant than for the wild-type receptor. In conclusion, in the hydrophobic pocket, two polar amino acids are able to interact through hydrogen bonds with bulky ligands depending on their chemical properties. Moreover, these experimental data may validate the proposed new three-dimensional model of the human 5-HT(4) receptor.

Indexed as

Amino AcidsAminobenzoatesAnimalsBinding, CompetitiveBinding SitesChlorocebus aethiopsCOS CellsHumansHydrophobic and Hydrophilic InteractionsIndolesModels, MolecularMutationpara-AminobenzoatesPiperidinesPropaneProtein Binding2-(3,5-dimethylpiperidino)ethyl 4-amino-5-chloro-2-methoxybenzoateAmino AcidsAminobenzoatesGR 113808Indolespara-AminobenzoatesPiperidinesPropaneReceptors, Serotonin, 5-HT4RS100235RS 39604SerotoninSulfonamidesTritium

Identifiers

PMID15351779
PMCPMC1575351
OpenAlexW1985813491

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.